HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Csaba Bödör Selected Research
Csaba Bödör Research Topics
Disease
12
Neoplasms (Cancer)
12/2023 - 07/2012
8
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2023 - 01/2017
7
Lymphoma (Lymphomas)
03/2024 - 03/2011
6
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2024 - 12/2008
5
Disease Progression
03/2023 - 10/2013
5
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 11/2006
3
Essential Thrombocythemia
04/2019 - 11/2006
3
Primary Myelofibrosis (Myelosclerosis)
04/2019 - 11/2006
2
Glioma (Gliomas)
10/2023 - 10/2022
2
Multiple Myeloma
01/2023 - 11/2018
2
Pathologic Complete Response
01/2023 - 01/2022
2
monosomy Chromosome 7
11/2022 - 06/2012
2
GATA2 Deficiency
11/2022 - 02/2016
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 01/2020
2
Leukemia
11/2021 - 01/2017
1
Brain Neoplasms (Brain Tumor)
12/2023
1
Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
11/2023
1
Glioblastoma (Glioblastoma Multiforme)
10/2023
1
Hypertrophy
09/2023
1
Melanoma (Melanoma, Malignant)
03/2023
1
Heart Failure
01/2023
1
Hemangiosarcoma (Angiosarcoma)
01/2023
1
Interdigitating Dendritic Cell Sarcoma
01/2022
1
Pathologic Processes
01/2022
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2018
1
Bone Marrow Failure Disorders
10/2018
1
Aplastic Anemia (Anemia, Hypoplastic)
10/2018
1
Juvenile Myelomonocytic Leukemia
10/2018
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1
Familial Acute Myeloid Leukemia with Mutated Cebpa
02/2016
1
Hematologic Neoplasms (Hematological Malignancy)
01/2016
1
Hairy Cell Leukemia
01/2016
1
Residual Neoplasm
01/2016
1
Mycosis Fungoides
07/2015
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2013
1
Breast Neoplasms (Breast Cancer)
01/2013
1
Liver Cell Adenoma (Hepatocellular Adenoma)
07/2012
1
Hamartoma
07/2012
1
Rhabdoid Tumor (Rhabdoid Tumors)
07/2012
1
Cystadenoma
07/2012
1
Neuroblastoma
07/2012
1
Cholangiocarcinoma
07/2012
1
Hepatocellular Carcinoma (Hepatoma)
07/2012
1
Rhabdomyosarcoma
07/2012
1
Wilms Tumor (Wilm's Tumor)
07/2012
1
Hepatoblastoma
07/2012
1
Trisomy (Trisomies)
06/2011
1
Acute Liver Failure (Fulminant Hepatic Failure)
11/2007
Drug/Important Bio-Agent (IBA)
10
Proteins (Proteins, Gene)
FDA Link
11/2023 - 11/2007
5
ibrutinib
IBA
01/2023 - 01/2019
3
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
03/2023 - 11/2006
3
Biomarkers (Surrogate Marker)
IBA
01/2023 - 03/2011
3
DNA (Deoxyribonucleic Acid)
IBA
01/2018 - 11/2006
2
Phosphotransferases (Kinase)
IBA
12/2023 - 03/2013
2
Immunoglobulins (Immunoglobulin)
IBA
01/2023 - 11/2021
2
MicroRNAs (MicroRNA)
IBA
01/2022 - 07/2015
2
Formaldehyde (Formol)
FDA Link
01/2022 - 06/2011
2
Tyrosine Kinase Inhibitors
IBA
01/2021 - 03/2017
2
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2020 - 01/2020
2
Messenger RNA (mRNA)
IBA
03/2011 - 05/2005
2
Cytidine Deaminase
IBA
12/2008 - 05/2005
1
Tyrosine (L-Tyrosine)
FDA Link
12/2023
1
Connectin
IBA
11/2023
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
10/2023
1
Angiotensin II
IBA
09/2023
1
AL 8810
IBA
09/2023
1
venetoclax
IBA
03/2023
1
Rituximab (Mabthera)
FDA Link
03/2023
1
Cell Surface Receptors
IBA
03/2023
1
larotrectinib
IBA
01/2023
1
Enhancer of Zeste Homolog 2 Protein
IBA
01/2023
1
Histones (Histone)
IBA
10/2022
1
Circulating Tumor DNA
IBA
01/2020
1
Phospholipase C gamma
IBA
01/2020
1
Calreticulin
IBA
04/2019
1
Monoclonal Antibodies
IBA
04/2019
1
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
10/2018
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
01/2018
1
Antibodies
IBA
01/2018
1
Transcription Factors (Transcription Factor)
IBA
01/2017
1
Interleukin-10 (Interleukin 10)
IBA
01/2017
1
Complement Receptors (Complement Receptor)
IBA
01/2017
1
telomerase RNA (bTR)
IBA
02/2016
1
RNA (Ribonucleic Acid)
IBA
01/2016
1
cytidylyl-(3'-5')-cytidine (CpC)
IBA
02/2014
1
Methyltransferases
IBA
10/2013
1
idelalisib
IBA
03/2013
1
Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)
IBA
01/2013
1
Zinc Finger Nucleases
IBA
01/2013
1
Dasatinib (BMS 354825)
FDA Link
07/2012
1
Plastics
IBA
06/2012
1
Paraffin
IBA
06/2011
1
HLA Antigens (Human Leukocyte Antigens)
IBA
03/2011
Therapy/Procedure
15
Therapeutics
03/2024 - 10/2013
2
Stem Cell Transplantation
11/2022 - 06/2012
2
Ligation
01/2020 - 11/2018
1
Immunotherapy
10/2023
1
Drug Therapy (Chemotherapy)
01/2022
1
Transplantation
10/2018
1
Hematopoietic Stem Cell Transplantation
10/2018